Is this you? Create Your Porfile
Avatar

Nyla A. Heerema

University of Texas MD Anderson Cancer Center

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Nyla A. Heerema is active.

Explore More

Publication

Featured researches published by Nyla A. Heerema.

Blood | 2006

Clinical implications of FLT3 mutations in pediatric AML

Soheil Meshinchi; Todd A. Alonzo; Derek L. Stirewalt; Michel Zwaan; Martin Zimmerman; Dirk Reinhardt; Gertjan J. L. Kaspers; Nyla A. Heerema; Robert B. Gerbing; Beverly J. Lange; Jerald P. Radich

Archive | 2016

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Association of Chromosome Arm 9p Abnormalities With Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group

Nyla A. Heerema; Harland N. Sather; Martha G. Sensel; Wen Liu-Mares; Beverly J. Lange; Bruce Bostrom; James Nachman; Peter G. Steinherz; Raymond J. Hutchinson; Paul S. Gaynon; Diane C. Arthur; Fatih M. Uckun

Archive | 2016

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group

Nyla A. Heerema; James Nachman; Harland N. Sather; Martha G. Sensel; Mei K. Lee; Raymond J. Hutchinson; Beverly J. Lange; Peter G. Steinherz; Bruce Bostrom; Paul S. Gaynon; Fatih M. Uckun

Archive | 2013

Group acute myeloid leukemia (AML): a report from the Children's Oncology Prevalence and prognostic implications of WT1 mutations in pediatric

Soheil Meshinchi; Derek L. Stirewalt; Nyla A. Heerema; Susana C. Raimondi; Betsy Hirsch; Anthony D. Ho; Rong Zeng; Todd A. Alonzo; Robert B. Gerbing; Kristen L. Miller; Jessica A. Pollard

Archive | 2013

Children's Oncology Group for standard-risk acute lymphoblastic leukemia, reported by the methotrexate: results of the Children's Cancer Group (CCG) 1952 study fails to improve event-free survival when compared with intrathecal Intrathecal triple therapy decreases central nervous system relapse but

M. Wells; April D. Sorrell; Margaret Masterson; John F. Kelleher; Linda C. Stork; Rochelle Yanofsky; Raymond J. Hutchinson; Nyla A. Heerema; James Nachman; Marilyn Blake; Linda Yousif Matloub; Susan Lindemulder; Paul S. Gaynon; Harland N. Sather; Emmett H. Broxson

Archive | 2013

myeloid leukemia: results of an international retrospective study Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute

Takashi Taga; Daisuke Tomizawa; David Webb; Zuzana Zemanová; C. Michel Zwaan; Jeffrey E. Rubnitz; Franklin O. Smith; Jan Stary; Irina Stasevich; Sabine Strehl; Anna Leszl; Nathalia Litvinko; Akira Morimoto; Christine Perot; Rob Pieters; Brenda Gibson; Henrik Hasle; Christine J. Harrison; Nyla A. Heerema; Myron Chang; Ursula Creutzig; M Dworzak; V. Balgobind; Susana C. Raimondi; Jochen Harbott; Martin Zimmermann; Todd A. Alonzo

Archive | 2012

Cytogenetics in Children, Adolescents and Young Adults with ALL and AML

Susana C. Raimondi; Nyla A. Heerema

Archive | 2011

cooperative trials for de novo AML patients with core binding factor AML enrolled on serial pediatric mutations in pediatric KIT Prevalence and prognostic significance of

Robert J. Arceci; Jerald P. Radich; Irwin D. Bernstein; Michael C. Heinrich; Susana C. Raimondi; Nyla A. Heerema; William G. Woods; Beverly J. Lange; Gary V. H. Dahl; Norman J. Lacayo; David L. Becton; Myron Chang; Howard J. Weinstein; Jessica A. Pollard; Todd A. Alonzo; Robert B. Gerbing; Phoenix A. Ho; Rong Zeng

Archive | 2011

Group acute myeloid leukemia (AML): a report from the Children's Oncology mutations in pediatric CEBPA Prevalence and prognostic implications of

Soheil Meshinchi; Nyla A. Heerema; Betsy Hirsch; Susana C. Raimondi; Beverly J. Lange; Jerald P. Phoenix; Amy C. Ho; Todd A. Alonzo; Robert B. Gerbing; Jessica A. Pollard; Derek L. Stirewalt; Craig A. Hurwitz

Archive | 2011

Cancer Group Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in

Beverly J. Lange; Peter G. Steinherz; Bruce Bostrom; Paul S. Gaynon; Fatih M. Uckun; Nyla A. Heerema; James Nachman; Harland N. Sather; Martha G. Sensel; Mei K. Lee

Explore More

Collaboration

Dive into the Nyla A. Heerema's collaboration.

Top Co-Authors
Avatar

Harland N. Sather

Children's Oncology Group

View shared research outputs
Top Co-Authors
Avatar

Paul S. Gaynon

University of California

View shared research outputs
Top Co-Authors
Avatar

Beverly J. Lange

Children's Oncology Group

View shared research outputs
Top Co-Authors
Avatar

Todd A. Alonzo

University of Minnesota

View shared research outputs
Top Co-Authors
Avatar

Susana C. Raimondi

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors
Avatar

James Nachman

University of Chicago

View shared research outputs
Top Co-Authors
Avatar

Peter G. Steinherz

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors
Avatar

Robert B. Gerbing

Children's Oncology Group

View shared research outputs
Top Co-Authors
Avatar

Fatih M. Uckun

University of Chicago

View shared research outputs
Top Co-Authors
Avatar

Martha G. Sensel

Children's Oncology Group

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge